News
Boise-based SWEAR was honored by Fast Company’s 2025 Innovation by Design Awards for AI design and data design innovation.
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback